SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Analysts at Raymond James decreased their Q1 2025 earnings per share (EPS) estimates for shares of SNC-Lavalin Group in a research report issued on Friday, March 14th. Raymond James analyst F. Bastien now forecasts that the company will earn $0.54 per share for the quarter, down from their prior estimate of $0.57. Raymond James also issued estimates for SNC-Lavalin Group’s Q2 2025 earnings at $0.65 EPS, Q4 2025 earnings at $0.82 EPS, Q1 2026 earnings at $0.70 EPS, Q2 2026 earnings at $0.84 EPS, Q3 2026 earnings at $1.01 EPS and Q4 2026 earnings at $0.85 EPS.
Separately, Stifel Canada upgraded SNC-Lavalin Group to a “strong-buy” rating in a report on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Featured Stories
- Five stocks we like better than SNC-Lavalin Group
- How to start investing in penny stocks
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Must-Own Stocks to Build Wealth This Decade
- The Significance of Brokerage Rankings in Stock Selection
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
